Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

被引:7
|
作者
Wang, Qian [1 ]
Xu, Chunwei [2 ,3 ,4 ]
Wang, Wenxian [3 ]
Zhang, Yongchang [5 ]
Li, Ziming [6 ]
Song, Zhengbo [3 ]
Wang, Jiandong [7 ]
Yu, Jinpu [8 ]
Liu, Jingjing [9 ]
Zhang, Shirong [10 ]
Cai, Xiuyu
Li, Wen [11 ]
Zhan, Ping [4 ]
Liu, Hongbing [4 ]
Lv, Tangfeng [4 ]
Miao, Liyun [12 ]
Min, Lingfeng [13 ]
Li, Jiancheng [14 ,15 ]
Liu, Baogang [16 ]
Yuan, Jingping [17 ]
Jiang, Zhansheng [18 ]
Lin, Gen [15 ,19 ]
Chen, Xiaohui [15 ,20 ]
Pu, Xingxiang [21 ]
Rao, Chuangzhou [22 ]
Lv, Dongqing [23 ]
Yu, Zongyang
Li, Xiaoyan
Tang, Chuanhao
Zhou, Chengzhi [24 ]
Zhang, Junping [25 ]
Guo, Hui [26 ]
Chu, Qian [27 ]
Meng, Rui [28 ]
Liu, Xuewen [29 ]
Wu, Jingxun [30 ]
Hu, Xiao [31 ]
Zhou, Jin [32 ]
Zhu, Zhengfei [33 ]
Chen, Xiaofeng [34 ,35 ]
Pan, Weiwei [36 ]
Pang, Fei [37 ]
Zhang, Wenpan [37 ]
Jian, Qijie [37 ]
Wang, Kai [37 ]
Wang, Liping [38 ]
Zhu, Youcai [39 ,40 ]
Yang, Guocai [41 ]
Lin, Xinqing [24 ]
Cai, Jing [42 ]
机构
[1] Nanjing Univ Chinese Med, Dept Resp Med, Jiangsu Prov Hosp Chinese Med, Nanjing, Peoples R China
[2] Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou, Peoples R China
[3] Univ Chinese Acad Sci, Dept Chemotherapy, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
[4] Nanjing Univ, Affiliated Jinling Hosp, Dept Resp Med, Med Sch, Nanjing, Peoples R China
[5] Cent South Univ, Dept Med Oncol, Lung Canc & Gastrointestinal Unit, Hunan Canc Hosp,Affiliated Canc Hosp,Xiangya Sch, Changsha, Peoples R China
[6] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Canc Ctr, Shanghai, Peoples R China
[7] Nanjing Univ, Affiliated Jinling Hosp, Dept Pathol, Med Sch, Nanjing, Peoples R China
[8] Tianjin Med Univ, Dept Canc Mol Diagnost Core, Canc Inst & Hosp, Tianjin, Peoples R China
[9] Jilin Canc Hosp, Dept Thorac Canc, Changchun, Peoples R China
[10] Zhejiang Univ, Translat Med Res Ctr, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Affiliated Hangzhou Peoples Hosp 1,Canc Ctr,Sch M, Hangzhou, Peoples R China
[11] Zhejiang Univ, Sch Med, Key Lab Resp Dis Zhejiang Prov, Ctr Canc,Dept Resp & Crit Care Med,Affiliated Hos, Hangzhou, Peoples R China
[12] Nanjing Univ, Affiliated Drum Tower Hosp, Dept Resp Med, Med Sch, Nanjing, Peoples R China
[13] Yangzhou Univ, Dept Resp Med, Clin Med Sch, Subei Peoples Hosp Jiangsu Prov, Yangzhou, Peoples R China
[14] Fujian Med Univ, Canc Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China
[15] Fujian Canc Hosp, Fuzhou, Peoples R China
[16] Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Peoples R China
[17] Wuhan Univ, Dept Pathol, Renmin Hosp, Wuhan, Peoples R China
[18] Tianjin Med Univ, Dept Integrat Oncol, Canc Inst & Hosp, Tianjin, Peoples R China
[19] Fujian Med Univ, Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China
[20] Fujian Med Univ, Canc Hosp, Dept Thorac Surg, Fuzhou, Peoples R China
[21] Cent South Univ, Xiangya Sch Med, Dept Med Oncol, Hunan Canc Hosp,Affiliated Canc Hosp, Changsha, Peoples R China
[22] Univ Chinese Acad Sci, Dept Radiotherapy & Chemotherapy, Hwamei Hosp, Ningbo, Peoples R China
[23] Wenzhou Med Univ, Taizhou Hosp, Dept Pulm Med, Taizhou, Peoples R China
[24] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Hlth, Natl Clin Res Ctr Resp Dis,Affiliated Hosp 1, Guangzhou, Peoples R China
[25] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Thorac Oncol, Taiyuan, Peoples R China
[26] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian, Peoples R China
[27] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[28] Huazhong Univ Sci & Technol, Canc Ctr, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China
[29] Cent South Univ, Xiangya Hosp 3, Dept Oncol, Changsha, Peoples R China
[30] Xiamen Univ, Affiliated Hosp Med 1, Dept Med Oncol, Xiamen, Peoples R China
[31] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Zhejiang Key Lab Radiat Oncol, Canc Hosp, Hangzhou, Peoples R China
[32] Univ Elect Sci & Technol, Dept Med Oncol, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr,Sch Med, Chengdu, Peoples R China
[33] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai, Peoples R China
[34] Jiangsu Prov Hosp, Dept Oncol, Nanjing, Peoples R China
[35] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Peoples R China
[36] Jiaxing Univ, Coll Med, Dept Cell Biol, Jiaxing, Peoples R China
[37] Shanghai OrigiMed Co Ltd, Dept Med, Shanghai, Peoples R China
[38] Baotou Canc Hosp, Dept Oncol, Baotou, Peoples R China
[39] Jiaxing Univ, Dept Thorac Dis, Zhejiang Rongjun Hosp, Affiliated Hosp 3, Jiaxing, Peoples R China
[40] Jiaxing Univ, Dis Diag & Treatment Ctr, Zhejiang Rongjun Hosp, Affiliated Hosp 3, Jiaxing, Peoples R China
[41] Wenzhou Med Univ, Zhoushan Hosp, Dept Thorac Surg, Wenzhou, Peoples R China
[42] Nanchang Univ, Dept Oncol, Affiliated Hosp 2, Nanchang, Peoples R China
[43] Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Pathol, Taiyuan, Peoples R China
[44] Anhui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
[45] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China
[46] Zhejiang Univ, Sch Med, Huzhou Hosp, Dept Resp Med, Huzhou, Peoples R China
[47] Lishui Municipal Cent Hosp, Deartment Oncol, Lishui, Peoples R China
[48] Xi An Jiao Tong Univ, Dept Oncol, Affiliated Hosp 2, Med Coll, Xian, Peoples R China
[49] Second Hosp Jilin Univ, Dept Pathol, Changchun, Peoples R China
[50] Peoples Liberat Army Gen Hosp, Med Ctr 5, Senior Dept Oncol, Beijing, Peoples R China
关键词
diagnosis; malignant pleural mesothelioma; prognosis; treatment; MODULATED RADIATION-THERAPY; PEMETREXED PLUS CARBOPLATIN; MULTICENTER PHASE-II; OPEN-LABEL; EXTRAPLEURAL PNEUMONECTOMY; HEMITHORACIC RADIATION; 1ST-LINE CHEMOTHERAPY; SURGICAL-MANAGEMENT; DOUBLE-BLIND; LUNG-CANCER;
D O I
10.1111/1759-7714.15022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and its incidence has been increasing in recent years. Due to the insidious onset and strong local invasiveness of MPM, most patients are diagnosed in the late stage and early screening and treatment for high-risk populations are crucial. The treatment of MPM mainly includes surgery, chemotherapy, and radiotherapy. Immunotherapy and electric field therapy have also been applied, leading to further improvements in patient survival. The Mesothelioma Group of the Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) developed a national consensus on the clinical diagnosis and treatment of MPM based on existing clinical research evidence and the opinions of national experts. This consensus aims to promote the homogenization and standardization of MPM diagnosis and treatment in China, covering epidemiology, diagnosis, treatment, and follow-up.
引用
收藏
页码:2715 / 2731
页数:17
相关论文
共 50 条
  • [21] Diagnosis and treatment of herpangina: Chinese expert consensus
    Hui Yu
    Xing-Wang Li
    Quan-Bo Liu
    Hui-Ling Deng
    Gang Liu
    Rong-Meng Jiang
    Ji-Kui Deng
    Ying-Zi Ye
    Jian-Hua Hao
    Ying-Hu Chen
    Guang-Min Nong
    Zhao-Bo Shen
    Chang-Shan Liu
    Ying-Xue Zou
    Jin-Zhun Wu
    Xing-Dong Wu
    Bi-Quan Chen
    Ru-Ping Luo
    Ai-Wei Lin
    Yan Chen
    Xiao-Dong Liu
    World Journal of Pediatrics, 2020, 16 : 129 - 134
  • [22] Chinese expert consensus on the diagnosis and treatment of balanoposthitis
    Zhang Li
    Abdulrahman Amer AA
    Guo Hao
    Zhang Jiaan
    Gao Xinghua
    Pan Weihua
    Wang Gang
    Xu Jinhua
    Shi Yuling
    Chen Liuqing
    Chen Hongxiang
    Geng Songmei
    Ran Yuping
    Wang Hongwei
    Man Xiaoyong
    Chang Jianmin
    Zhang Furen
    Zhang Litao
    Yin Guangwen
    Zhang Jianzhong
    Lai Wei
    Niu Zhibin
    Jiang Hongkun
    Liu Haibo
    Chen Yaolong
    Wang Jianjian
    中华医学杂志英文版, 2024, 137 (13)
  • [23] Treatment of malignant pleural mesothelioma
    Alolayan, Ashwaq
    Saadeddin, Ahmed
    Bamousa, Ahmed
    Jazieh, Abdul-Rahman
    ANNALS OF THORACIC MEDICINE, 2010, 5 (05) : S71 - S75
  • [24] Treatment of malignant pleural mesothelioma
    Rusch, VW
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 18 (04) : 363 - 373
  • [25] Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
    Mastromarino, Maria Giovanna
    Aprile, Vittorio
    Lucchi, Marco
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] CYTOLOGIC DIAGNOSIS OF MALIGNANT PLEURAL MESOTHELIOMA
    BERGE, T
    GRONTOFT, O
    ACTA CYTOLOGICA, 1965, 9 (03) : 207 - +
  • [27] Clinical diagnosis of malignant pleural mesothelioma
    Bianco, Andrea
    Valente, Tullio
    De Rimini, Maria Luisa
    Sica, Giacomo
    Fiorelli, Alfonso
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S253 - S261
  • [28] PLEURAL BIOPSY IN THE DIAGNOSIS OF MALIGNANT MESOTHELIOMA
    HERBERT, A
    GALLAGHER, PJ
    THORAX, 1982, 37 (11) : 816 - 821
  • [29] Cytological diagnosis of malignant pleural mesothelioma
    Siaw Ming Chai
    Chris Van Vliet
    Current Pulmonology Reports, 2017, 6 (1) : 1 - 8
  • [30] MALIGNANT PLEURAL MESOTHELIOMA - DIFFICULTIES IN DIAGNOSIS
    JACKSON, DV
    MARSHALL, RB
    ALBERTSON, DA
    SLATKOFF, ML
    NORTH CAROLINA MEDICAL JOURNAL, 1982, 43 (02) : 118 - 119